Similar articles

• [Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement].

  Toyohira H, Nakamura K, Kariyazono H, Yamada K, Moriyama Y, Shimokawa S, Saigenji H, Taira A. Toyohira H, et al. Kyobu Geka. 1995 Aug;48(9):749-55. Kyobu Geka. 1995. PMID: 7564036 Clinical Trial. Japanese.
• [Antithrombogenic therapy by use of antiplatelet agents with warfarin--its efficiency for the outpatients with prosthetic valve].

  Saitoh H. Saitoh H. Nihon Kyobu Geka Gakkai Zasshi. 1988 Nov;36(11):2396-407. Nihon Kyobu Geka Gakkai Zasshi. 1988. PMID: 3209894 Japanese. No abstract available.
• [Evaluation of antiplatelet drugs on platelet functions--comparison between ticlopidine and dipyridamole after prosthetic valve replacement].

  Saitoh H, Matsumoto H, Takayama T, Ide H, Miyawaki F, Furuse A. Saitoh H, et al. Kokyu To Junkan. 1989 Jan;37(1):87-92. Kokyu To Junkan. 1989. PMID: 2734499 Japanese.
• [Thrombosis prevention and platelet functions following heart valve replacement].

  Aosaki M, Kitamura N. Aosaki M, et al. Nihon Rinsho. 1978 Dec 10;36(12):3874-83. Nihon Rinsho. 1978. PMID: 372627 Review. Japanese. No abstract available.
• [Prevention of thromboembolism following heart valve replacement].

  van de Loo J, Stenzinger W. van de Loo J, et al. Verh Dtsch Ges Inn Med. 1989;95:275-82. Verh Dtsch Ges Inn Med. 1989. PMID: 2690497 Review. German. No abstract available.